Prasterone sulfate
Identification
- Generic Name
- Prasterone sulfate
- DrugBank Accession Number
- DB05804
- Background
DHEA sulfate is the major steroid of the fetal adrenal. DHEA-S is the principal adrenal androgen and is secreted together with cortisol under the control of ACTH and prolactin. DHEA-S is elevated with hyperprolactinemia.
- Type
- Small Molecule
- Groups
- Investigational
- Structure
- Weight
- Average: 368.488
Monoisotopic: 368.165744696 - Chemical Formula
- C19H28O5S
- Synonyms
- (3-beta)-3-(Sulfooxy)androst-5-en-17-one
- 17-Ketoandrost-5-en-3beta-yl sulfate
- 17-oxoandrost-5-en-3β-yl hydrogen sulphate
- 3-O-Sulfodehydroepiandrosterone
- 3beta-Hydroxyandrost-5-en-17-one 3-sulfate
- Androst-5-en-17-on-3beta-yl sulfuric acid
- Dehydroepiandrosterone 3-sulfate
- Dehydroepiandrosterone monosulfate
- Dehydroepiandrosterone sulfate
- Dehydroepiandrosterone sulphate
- Dehydroisoandrosterone sulfate
- Dehydroisoandrosterone-3-sulfate
- DHEA sulfate
- DHEA sulphate
- DHEA-S
- Prasterone sulphate
Pharmacology
- Indication
Investigated for use/treatment in asthma and burns and burn infections.
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
The low levels of dehydroepiandrosterone sulfate(DHEA-S)is associated with unfavorable levels of several strong cardiovascular disease risk factors, such as lipids and blood pleasure, which are components of the metabolic syndrome, and insulin levels. DHEA-S deficiency is risk factors of obesity and insulin resistance, but it is not clear, whether this possible influence is independent.
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
Pathway Category 17-beta Hydroxysteroid Dehydrogenase III Deficiency Disease Androgen and Estrogen Metabolism Metabolic Aromatase Deficiency Disease - Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Drug Interaction Integrate drug-drug
interactions in your softwareAbatacept The metabolism of Prasterone sulfate can be increased when combined with Abatacept. Adalimumab The metabolism of Prasterone sulfate can be increased when combined with Adalimumab. Alfentanil The metabolism of Prasterone sulfate can be decreased when combined with Alfentanil. Alprazolam The metabolism of Prasterone sulfate can be decreased when combined with Alprazolam. Anakinra The metabolism of Prasterone sulfate can be increased when combined with Anakinra. - Food Interactions
- Not Available
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Product Ingredients
Ingredient UNII CAS InChI Key Prasterone sodium sulfate anhydrous B9840IHU4T 1099-87-2 GFJWACFSUSFUOG-XPCIFDRISA-M - International/Other Brands
- Inflarest
Categories
- Drug Categories
- 17-Ketosteroids
- Adrenal Cortex Hormones
- Androstanes
- Androstenes
- Androstenols
- BSEP/ABCB11 Substrates
- Cytochrome P-450 CYP3A7 Substrates
- Dehydroepiandrosterone
- Fused-Ring Compounds
- Gonadal Hormones
- Gonadal Steroid Hormones
- Hormones
- Hormones, Hormone Substitutes, and Hormone Antagonists
- Ketosteroids
- Steroids
- Testosterone Congeners
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as sulfated steroids. These are sterol lipids containing a sulfate group attached to the steroid skeleton.
- Kingdom
- Organic compounds
- Super Class
- Lipids and lipid-like molecules
- Class
- Steroids and steroid derivatives
- Sub Class
- Sulfated steroids
- Direct Parent
- Sulfated steroids
- Alternative Parents
- Androstane steroids / 17-oxosteroids / Delta-5-steroids / Sulfuric acid monoesters / Alkyl sulfates / Ketones / Organic oxides / Hydrocarbon derivatives
- Substituents
- 17-oxosteroid / Aliphatic homopolycyclic compound / Alkyl sulfate / Androstane-skeleton / Carbonyl group / Delta-5-steroid / Hydrocarbon derivative / Ketone / Organic oxide / Organic oxygen compound
- Molecular Framework
- Aliphatic homopolycyclic compounds
- External Descriptors
- steroid sulfate, 17-oxo steroid (CHEBI:16814) / sulfates, C19 steroids (androgens) and derivatives, Androgens (C04555) / Sulfates (LMST05020010)
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 57B09Q7FJR
- CAS number
- 651-48-9
- InChI Key
- CZWCKYRVOZZJNM-USOAJAOKSA-N
- InChI
- InChI=1S/C19H28O5S/c1-18-9-7-13(24-25(21,22)23)11-12(18)3-4-14-15-5-6-17(20)19(15,2)10-8-16(14)18/h3,13-16H,4-11H2,1-2H3,(H,21,22,23)/t13-,14-,15-,16-,18-,19-/m0/s1
- IUPAC Name
- [(3aS,3bR,7S,9aR,9bS,11aS)-9a,11a-dimethyl-1-oxo-1H,2H,3H,3aH,3bH,4H,6H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-yl]oxidanesulfonic acid
- SMILES
- [H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@H](CC[C@]12C)OS(O)(=O)=O
References
- General References
- Altman R, Motton DD, Kota RS, Rutledge JC: Inhibition of vascular inflammation by dehydroepiandrosterone sulfate in human aortic endothelial cells: roles of PPARalpha and NF-kappaB. Vascul Pharmacol. 2008 Feb-Mar;48(2-3):76-84. doi: 10.1016/j.vph.2007.12.002. Epub 2007 Dec 15. [Article]
- Rabijewski M, Papierska L, Kozakowski J, Zgliczynski W: [The relationship between androgens concentrations (testosterone and dehydroepiandrosterone sulfate) and metabolic syndrome in non-obese elderly men]. Endokrynol Pol. 2007 Nov-Dec;58(6):496-504. [Article]
- Geyer J, Doring B, Meerkamp K, Ugele B, Bakhiya N, Fernandes CF, Godoy JR, Glatt H, Petzinger E: Cloning and functional characterization of human sodium-dependent organic anion transporter (SLC10A6). J Biol Chem. 2007 Jul 6;282(27):19728-41. Epub 2007 May 9. [Article]
- External Links
- Human Metabolome Database
- HMDB0001032
- KEGG Compound
- C04555
- PubChem Compound
- 12594
- PubChem Substance
- 175427036
- ChemSpider
- 12074
- BindingDB
- 50375559
- ChEBI
- 16814
- ChEMBL
- CHEMBL259898
- ZINC
- ZINC000004096458
- PDBe Ligand
- ZWY
- Wikipedia
- Dehydroepiandrosterone_sulfate
- PDB Entries
- 8gk3 / 8hw4 / 8sid / 8sx7
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.00806 mg/mL ALOGPS logP 0.49 ALOGPS logP 3.42 Chemaxon logS -4.7 ALOGPS pKa (Strongest Acidic) -1.4 Chemaxon pKa (Strongest Basic) -7.5 Chemaxon Physiological Charge -1 Chemaxon Hydrogen Acceptor Count 4 Chemaxon Hydrogen Donor Count 1 Chemaxon Polar Surface Area 80.67 Å2 Chemaxon Rotatable Bond Count 2 Chemaxon Refractivity 94.65 m3·mol-1 Chemaxon Polarizability 39.85 Å3 Chemaxon Number of Rings 4 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
Property Value Probability Human Intestinal Absorption + 0.996 Blood Brain Barrier + 0.9388 Caco-2 permeable - 0.6601 P-glycoprotein substrate Non-substrate 0.507 P-glycoprotein inhibitor I Inhibitor 0.6926 P-glycoprotein inhibitor II Non-inhibitor 0.9548 Renal organic cation transporter Non-inhibitor 0.7909 CYP450 2C9 substrate Non-substrate 0.8322 CYP450 2D6 substrate Non-substrate 0.8338 CYP450 3A4 substrate Substrate 0.6799 CYP450 1A2 substrate Non-inhibitor 0.8203 CYP450 2C9 inhibitor Non-inhibitor 0.84 CYP450 2D6 inhibitor Non-inhibitor 0.882 CYP450 2C19 inhibitor Non-inhibitor 0.8117 CYP450 3A4 inhibitor Non-inhibitor 0.9481 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.7575 Ames test Non AMES toxic 0.5802 Carcinogenicity Non-carcinogens 0.586 Biodegradation Not ready biodegradable 0.9519 Rat acute toxicity 2.4168 LD50, mol/kg Not applicable hERG inhibition (predictor I) Strong inhibitor 0.5859 hERG inhibition (predictor II) Inhibitor 0.5409
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 199.0577482 predictedDarkChem Lite v0.1.0 [M-H]- 196.9363482 predictedDarkChem Lite v0.1.0 [M-H]- 197.5383482 predictedDarkChem Lite v0.1.0 [M-H]- 193.30307 predictedDeepCCS 1.0 (2019) [M-H]- 199.0577482 predictedDarkChem Lite v0.1.0 [M-H]- 196.9363482 predictedDarkChem Lite v0.1.0 [M-H]- 197.5383482 predictedDarkChem Lite v0.1.0 [M-H]- 193.30307 predictedDeepCCS 1.0 (2019) [M+H]+ 198.5184482 predictedDarkChem Lite v0.1.0 [M+H]+ 197.4853482 predictedDarkChem Lite v0.1.0 [M+H]+ 197.7739482 predictedDarkChem Lite v0.1.0 [M+H]+ 195.69864 predictedDeepCCS 1.0 (2019) [M+H]+ 198.5184482 predictedDarkChem Lite v0.1.0 [M+H]+ 197.4853482 predictedDarkChem Lite v0.1.0 [M+H]+ 197.7739482 predictedDarkChem Lite v0.1.0 [M+H]+ 195.69864 predictedDeepCCS 1.0 (2019) [M+Na]+ 198.7701482 predictedDarkChem Lite v0.1.0 [M+Na]+ 197.1993482 predictedDarkChem Lite v0.1.0 [M+Na]+ 201.61128 predictedDeepCCS 1.0 (2019) [M+Na]+ 198.7701482 predictedDarkChem Lite v0.1.0 [M+Na]+ 197.1993482 predictedDarkChem Lite v0.1.0 [M+Na]+ 201.61128 predictedDeepCCS 1.0 (2019)
Enzymes
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- Actions
- Inducer
- General Function
- Oxygen binding
- Specific Function
- Catalyzes the formation of aromatic C18 estrogens from C19 androgens.
- Gene Name
- CYP19A1
- Uniprot ID
- P11511
- Uniprot Name
- Aromatase
- Molecular Weight
- 57882.48 Da
References
- Jones ME, Boon WC, McInnes K, Maffei L, Carani C, Simpson ER: Recognizing rare disorders: aromatase deficiency. Nat Clin Pract Endocrinol Metab. 2007 May;3(5):414-21. [Article]
- ElBeltagy K, Honda K, Ozaki K, Misugi T, Tokuyama O, Kimura M, Kira Y, Ishiko O: In vitro effect of dehydroepiandrosterone sulfate on steroid receptors, aromatase, cyclooxygenase-2 expression, and steroid hormone production in preovulatory human granulosa cells. Fertil Steril. 2007 Oct;88(4 Suppl):1135-42. Epub 2007 Jun 4. [Article]
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- Actions
- Substrate
- General Function
- Oxygen binding
- Specific Function
- Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally un...
- Gene Name
- CYP3A7
- Uniprot ID
- P24462
- Uniprot Name
- Cytochrome P450 3A7
- Molecular Weight
- 57525.03 Da
References
- Bacsi K, Kosa JP, Borgulya G, Balla B, Lazary A, Nagy Z, Horvath C, Speer G, Lakatos P: CYP3A7*1C polymorphism, serum dehydroepiandrosterone sulfate level, and bone mineral density in postmenopausal women. Calcif Tissue Int. 2007 Mar;80(3):154-9. Epub 2007 Mar 3. [Article]
- Smit P, van Schaik RH, van der Werf M, van den Beld AW, Koper JW, Lindemans J, Pols HA, Brinkmann AO, de Jong FH, Lamberts SW: A common polymorphism in the CYP3A7 gene is associated with a nearly 50% reduction in serum dehydroepiandrosterone sulfate levels. J Clin Endocrinol Metab. 2005 Sep;90(9):5313-6. Epub 2005 Jun 28. [Article]
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- Actions
- Inducer
- General Function
- Prostaglandin-endoperoxide synthase activity
- Specific Function
- Converts arachidonate to prostaglandin H2 (PGH2), a committed step in prostanoid synthesis. Constitutively expressed in some tissues in physiological conditions, such as the endothelium, kidney and...
- Gene Name
- PTGS2
- Uniprot ID
- P35354
- Uniprot Name
- Prostaglandin G/H synthase 2
- Molecular Weight
- 68995.625 Da
References
- ElBeltagy K, Honda K, Ozaki K, Misugi T, Tokuyama O, Kimura M, Kira Y, Ishiko O: In vitro effect of dehydroepiandrosterone sulfate on steroid receptors, aromatase, cyclooxygenase-2 expression, and steroid hormone production in preovulatory human granulosa cells. Fertil Steril. 2007 Oct;88(4 Suppl):1135-42. Epub 2007 Jun 4. [Article]
Transporters
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- General Function
- Sodium-independent organic anion transmembrane transporter activity
- Specific Function
- Plays an important role in the excretion/detoxification of endogenous and exogenous organic anions, especially from the brain and kidney. Involved in the transport basolateral of steviol, fexofenad...
- Gene Name
- SLC22A8
- Uniprot ID
- Q8TCC7
- Uniprot Name
- Solute carrier family 22 member 8
- Molecular Weight
- 59855.585 Da
References
- Cha SH, Sekine T, Fukushima JI, Kanai Y, Kobayashi Y, Goya T, Endou H: Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney. Mol Pharmacol. 2001 May;59(5):1277-86. [Article]
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- General Function
- Sodium-independent organic anion transmembrane transporter activity
- Specific Function
- Mediates the Na(+)-independent transport of organic anions such as sulfobromophthalein (BSP) and conjugated (taurocholate) and unconjugated (cholate) bile acids (By similarity). Selectively inhibit...
- Gene Name
- SLCO1A2
- Uniprot ID
- P46721
- Uniprot Name
- Solute carrier organic anion transporter family member 1A2
- Molecular Weight
- 74144.105 Da
References
- Kullak-Ublick GA, Ismair MG, Stieger B, Landmann L, Huber R, Pizzagalli F, Fattinger K, Meier PJ, Hagenbuch B: Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. Gastroenterology. 2001 Feb;120(2):525-33. [Article]
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- General Function
- Sodium-independent organic anion transmembrane transporter activity
- Specific Function
- Mediates the Na(+)-independent uptake of organic anions such as pravastatin, taurocholate, methotrexate, dehydroepiandrosterone sulfate, 17-beta-glucuronosyl estradiol, estrone sulfate, prostagland...
- Gene Name
- SLCO1B1
- Uniprot ID
- Q9Y6L6
- Uniprot Name
- Solute carrier organic anion transporter family member 1B1
- Molecular Weight
- 76447.99 Da
References
- Kullak-Ublick GA, Ismair MG, Stieger B, Landmann L, Huber R, Pizzagalli F, Fattinger K, Meier PJ, Hagenbuch B: Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. Gastroenterology. 2001 Feb;120(2):525-33. [Article]
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- General Function
- Sodium-independent organic anion transmembrane transporter activity
- Specific Function
- Mediates the Na(+)-independent uptake of organic anions such as 17-beta-glucuronosyl estradiol, taurocholate, triiodothyronine (T3), leukotriene C4, dehydroepiandrosterone sulfate (DHEAS), methotre...
- Gene Name
- SLCO1B3
- Uniprot ID
- Q9NPD5
- Uniprot Name
- Solute carrier organic anion transporter family member 1B3
- Molecular Weight
- 77402.175 Da
References
- Kullak-Ublick GA, Ismair MG, Stieger B, Landmann L, Huber R, Pizzagalli F, Fattinger K, Meier PJ, Hagenbuch B: Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. Gastroenterology. 2001 Feb;120(2):525-33. [Article]
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- General Function
- Sodium-independent organic anion transmembrane transporter activity
- Specific Function
- Mediates the Na(+)-independent transport of organic anions such as taurocholate, the prostaglandins PGD2, PGE1, PGE2, leukotriene C4, thromboxane B2 and iloprost.
- Gene Name
- SLCO2B1
- Uniprot ID
- O94956
- Uniprot Name
- Solute carrier organic anion transporter family member 2B1
- Molecular Weight
- 76709.98 Da
References
- Kullak-Ublick GA, Ismair MG, Stieger B, Landmann L, Huber R, Pizzagalli F, Fattinger K, Meier PJ, Hagenbuch B: Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. Gastroenterology. 2001 Feb;120(2):525-33. [Article]
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- General Function
- Sodium-dependent organic anion transmembrane transporter activity
- Specific Function
- Transports sulfoconjugated steroid hormones, as well as taurolithocholic acid-3-sulfate and sulfoconjugated pyrenes in a sodium-dependent manner.
- Gene Name
- SLC10A6
- Uniprot ID
- Q3KNW5
- Uniprot Name
- Solute carrier family 10 member 6
- Molecular Weight
- 41258.24 Da
References
- Geyer J, Doring B, Meerkamp K, Ugele B, Bakhiya N, Fernandes CF, Godoy JR, Glatt H, Petzinger E: Cloning and functional characterization of human sodium-dependent organic anion transporter (SLC10A6). J Biol Chem. 2007 Jul 6;282(27):19728-41. Epub 2007 May 9. [Article]
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- No
- Actions
- Substrate
- General Function
- Transporter activity
- Specific Function
- Involved in the ATP-dependent secretion of bile salts into the canaliculus of hepatocytes.
- Gene Name
- ABCB11
- Uniprot ID
- O95342
- Uniprot Name
- Bile salt export pump
- Molecular Weight
- 146405.83 Da
References
- Pedersen JM, Matsson P, Bergstrom CA, Hoogstraate J, Noren A, LeCluyse EL, Artursson P: Early identification of clinically relevant drug interactions with the human bile salt export pump (BSEP/ABCB11). Toxicol Sci. 2013 Dec;136(2):328-43. doi: 10.1093/toxsci/kft197. Epub 2013 Sep 6. [Article]
Drug created at November 18, 2007 18:27 / Updated at February 19, 2024 14:28